Iran starts trial of new homegrown vaccine as campaign lags
Read full article: Iran starts trial of new homegrown vaccine as campaign lagsIran says that its third homegrown vaccine has reached the phase of clinical trials, even as details about its production remained slim. AdBut details are scant about the Islamic Republic's vaccine production efforts. Two other Iranian vaccines are also in the phase of clinical trials, with the most advanced, called Barekat, tested on 300 people so far. Earlier this week, the government launched a vaccine production factory it claims can make 3 million doses a day. Iran formally launched its limited vaccination campaign last month, doling out Russia's Sputnik V vaccine to health workers and those with chronic health conditions.